The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
It’s so funny how the investors troll a share and then disappear when they get their buy price. Very transparent. It happens all the time on SNG. Very sad individuals populate these boards and twitter.
Well IMO the CEO is about to burn the shorters and trolls with some exciting news. Let’s see the TR1 land first then the serious news flow.
This share has been shorted and has had a headwind for the last few months.
Things are now changing and at this level IMO it offers investors significant opportunity.
Obviously DYOR and only invest what you can afford.
We could easily see IMO 500% on news. The free float is tiny.
GLA
Wow some Real negativity on this board tonight.
We need more PMA here !
We all know News is overdue!
Call it what you want. This has created the headwind which has kept the price low. The delayed sells after the 24th (cross date on RNS) clearly demonstrate they are close to clearing the remaining 1.9b shares. This is a good thing IMO !
Another 500m of delayed trades popped up today after hours. The seller had 1.9b left on the last TR1 RNS.
This week they have cleared close to 1.5b. More delays will show tomorrow. The seller is on fumes. The headwinds are close to vanishing imo. DYOR
Morning all
I have been buying shares here over the last 48hrs.
I really like the companies core investments, however it was the T-Cell vaccine that was the icing on the cake.
As you know I was heavy in SNG. I now believe this company has an opportunity to re-rate once the awful Acacia Research exit. They are clearing applying the same strategy as they have done elsewhere and will clear all shares in the next few weeks. I expect a TR1 soon after Monday’s volume.
Well done to investors who bought in at 6p level and below. I believe this share could see 50p over the next month. Please DYOR !
Morning board
I am new to this share. I used my SNG profits to buy this morning and plan to build a nice substantial holding. I’m just glad I had the opportunity to buy at 50p. I can see this bagging in the next few weeks. Great to be part of this share !
Morning all
What a wonderful day yesterday for us all.
Well done everyone that held through the trolls.
Nolupus it I hope you are please with the results.
I’m have now de-risked and enjoying a free ride.
Money heading into another pharma now, as it’s well undervalued as well. GLA !
Evening All
103 posts on a Sunday. This share is getting noticed !
Well after the trades on Friday, we are in for a special week ahead.... what’s special.... well some might think that Nolupus is on holiday and won’t post, that would be special, but what’s more interesting is that on my numbers Acacia is down to or below 3m and we have a very hungry buyer ! We have 10 working days to news. SYNAIRGEN patents are broad and secure. Every piece of research I have read on Interferon haas been positive and we have 3 gold standard phase 2 trials running with two about to be published ( I think Friday at 4.30pm).
We have had a placing, Griff selling, Lansdowne selling and Acacia selling. It’s been tough to hold on the swings. In majority the standard of research and posts here have been beyond great (yes even Nolupus once be bought in).
So good luck all. Enjoy next week !!
My Maths is different.
1m delay earlier this week
500k delay earlier this week
200k delay last night
Yesterday trades
1m trade
1.9m trade
500k trade
2m trade
Over 1m of 50k and 30k trades.
Total this week of delays and chunky and we are pushing their 10.2m holding.
More importantly the Interferon report on the identification of low Interferon in blood could be significant for early intervention Interferon drugs that can be directed to lungs..... oh just like SNG001!!!
Just traded
If you are holding for news, are you feeling the excitement increase. Only 10 days 3 hours of trading left in July.
Let’s not forget Synairgen is also involved in the Dragon project, solidarity project along with their 3 phase 2 trials.
Also this is a multi virus drug. We know from the COPD trials we will receive multivirus data.
Nolupus I know we have not seen eye to eye, but I believe your heart is in the right place. I hope you, i and all genuine investors make some decent ££ off our investment. I also truly hope SNG001 is as good as we think it is.... the planet needs this to work.
GLA !
Can see this back in 40’s Tomorrow.
FOMO will kick in with some and others just won’t want to be out of this over the weekend.... who can blame them.
Lunus1 I respectfully disagree.
Every video, every interview and every direct conversation There has been A consistent theme. This will be too big for Synairgen alone. They have had a team working on the exit strategy / partnership strategy since April.
Looks like the Sheriff is back in town. Subtle de-ramping until they remember they bought 50 shares.
Only 11.5 trading days left in July, so not long now.
I think we will hear next week !
Advanced warning - share can go up and down !
So my expectations on positive results for COPD were between £200m and £250m. So let’s say £1.50 per share.
If C-19 results show a small benefit and drug approval by FDA and MHRA is likely, I would increase the valuation to between £250m and £500m.
Equally for balance on poor results we could see a drop into 20’s, whilst we await home trials.
TR1 Buyer !
Crl123 I am expecting one last twist to the story prior to news. Let’s see if I’m right !
500k delay from yesterday is now showing !